Stocks and Investing Stocks and Investing
Thu, February 23, 2023

Andrew Fein Reiterated (UTHR) at Strong Buy and Held Target at $300 on, Feb 23rd, 2023


Published on 2024-10-28 01:49:07 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "United Therapeutics Corporation" (UTHR) at Strong Buy and Held Target at $300 on, Feb 23rd, 2023.

Andrew has made no other calls on UTHR in the last 4 months.



There are 5 other peers that have a rating on UTHR. Out of the 5 peers that are also analyzing UTHR, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Andrew


  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $300 on, Wednesday, January 11th, 2023
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $320 on, Tuesday, December 6th, 2022
  • Chris Shibutani of "Goldman Sachs" Initiated at Strong Sell and Held Target at $230 on, Monday, December 5th, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $375 on, Thursday, November 3rd, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $265 on, Thursday, November 3rd, 2022

Contributing Sources